Major research project: Evaluation of Dalbavancin Regimen Efficacy and
Effects on Patient Outcomes
Faith Collum, PharmD
Major research project: Head, shoulders, knees and toes – Effects
of adding nerve blocks to Zynrelef or Exparel on patient outcomes
Past Residents
Jessica Doan, PharmD
2024-2025 PGY1 Resident
Major research project: Evaluating the impact of a pharmacy auto-discontinuation
protocol on vancomycin duration and adverse eventCE Seminar: Review and
aDAPT the Management of Percutaneous Coronary Intervention (PCI)Changes
to hospital or pharmacy practice made during PGY1 residency year:
Extravasation protocol
Updated the stability of anti-neoplastic compounded agents chart
First position after finishing PGY1: Oncology ambulatory care pharmacist at UTSW
Delilah Knapp, PharmD
2024-2025 PGY1 Resident
Major research project: Assessing Variations in DKA Protocol Compliance
and Safety Outcomes between emergency medicine and inpatient units
CE Seminar: Hemophilia A/B and Von Willebrand Disease
Changes to hospital or pharmacy practice made during PGY1 residency year:
Updated pharmacy autosubstitution protocol with ten new drugs
Created autosubstitution protocol for phosphate binders based on lab values
Urine and blood culture pharmacist decision-making guideline
First position after finishing PGY1: PGY2 Emergency Medicine Residency
at Riverside University Health System
Hannah Noxon, PharmD
2023-2024 PGY1 Resident
Major research project: Treatment of mild to moderate diabetic ketoacidosis
on an intermediate care unit utilizing a nursing-driven intravenous protocol
CE Seminar: Evaluation of DOAC use in patients with altered gastrointestinal systems
Changes to hospital or pharmacy practice made during PGY1 residency year:
Updated pharmacy anticoagulation protocol
Dornase alfa drug class review and MUE
First position after finishing PGY1: PGY2 Critical Care Residency at University
Health System
Current position: Emergency medicine pharmacist specialist at MCMC
Rachel Chock, PharmD
2022-2023 PGY1 Resident
Major research project: Clinical impact of a pharmacist-driven diabetes
clinic on a suburban Dallas population in a “COVID-19 experienced”
healthcare setting
CE Seminar: ADA guideline update and pipeline drugs for diabetes
Changes to hospital or pharmacy practice made during PGY1 residency year:
Chemotherapy reference chart
Stability of reconstituted compounded items
Palonosetron autosubstitution
Retacrit auto-discontinuation policy MUE and formulary restriction update
First position after finishing PGY1: Transitions of Care Pharmacist at UTSW
Current position: Transplant pharmacist specialist at UTSW
Leandra Garcia, PharmD
2022-2023 PGY1 Resident
Major research project: Evaluation of the use of tranexamic acid (TXA)
for ACE inhibitor-induced angioedema in the emergency department
CE Seminar: ACE inhibitor-induced angioedema treatment
Changes to hospital or pharmacy practice made during PGY1 residency year:
RSI Order set
Hypertonic saline IV administration guidelines update
Sugammadex formulary addition
First position after finishing PGY1: PGY2 emergency medicine at UW Health
SwedishAmerican Hospital
Current position: Emergency medicine specialist at MCMC
Kevin Burnham, PharmD
2021-2022 PGY1 Resident
Major research project: Utility assessment of a pharmacy to dose Daptomycin
protocol: a retrospective cohort study
CE Seminar: Review of antimicrobial-resistant gram negative infection (AMR
2.0) treatment guidelines
Changes to hospital or pharmacy practice made during PGY1 residency year:
Peripheral administration of hypertonic saline and mannitol
Humate-P dosing and preparation review for pharmacists
Kcentra formulary restriction updates and MUE
Creation of hypertriglyceridemia-induced pancreatitis order set
Creation of peritoneal dialysis order set including antimicrobials
First position after finishing PGY1: Emergency medicine specialist at MCMC
Current position: Entered medical school in 2025
Rubya Khalid, PharmD
2020-2021 PGY1 Resident
Major research project: Comparison of vancomycin AUC outcomes – beyond
the guidelines for serious MRSA infections
CE Seminar: Anticoagulation use in COVID-19
Changes to hospital or pharmacy practice made during PGY1 residency year:
Creation of an argatroban-warfarin bridging treatment guideline
First position after finishing PGY1: PRN Clinical pharmacist at MCMC
